Anbio Biotechnology (NNNN) Non-Current Receivables (2023)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Anbio Biotechnology has reported Non-Current Receivables over the past 1 years, most recently at $18009.0 for Q4 2023.

• Quarterly results put Non-Current Receivables at $18009.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $18009.0 (changed N/A YoY), and the annual figure for FY2023 was $18009.0, changed.
• Non-Current Receivables for Q4 2023 was $18009.0 at Anbio Biotechnology.
• Over the last five years, Non-Current Receivables for NNNN hit a ceiling of $18009.0 in Q4 2023 and a floor of $18009.0 in Q4 2023.

Peer Comparison